Navigation Links
BIA and Catalyst Release Per-Document Review & Hosting, a Cost-Effective Package
Date:1/26/2010

bility, and integrity assurance of the documents throughout the process.  The benefits of this evolution towards more predictability and cost controls follows BIA's Electronically Stored Information (ESI) model of per-document pricing.  The offering includes:

  • Predictable Pricing Model (per-document pricing, not per-page)
  • Mature & Feature-Rich Online Review Platform
  • Guaranteed Quality Control & Process Efficiency
  • ISO 9001:2008-Certified Quality Management System for Document Review Services
  • 6-Month Hosting Per Document Included

"Working closely with BIA, we have created a synergy – a seamless, defensible e-discovery & document review strategy for our clients that offers predictable pricing tailored to meet each budget," said Christopher Toomey, Director of Managed Review at Catalyst.  "Our clients derive the benefit of BIA's process efficiencies and highly skilled, Catalyst-certified attorneys, along with our advanced analytics and review technology, all within a secure hosting environment."  

The relationship that spans half a decade between these two companies is fiercely credentialed, both having long-established efficiencies in all of their processes through years of research and development.  Mack echoes Toomey's comments.

"Our attorneys are trained, certified, and trainers themselves in the use and application of Catalyst's review tool.  This knowledge greatly decreases any learning curves related to any projects and enhances our review effectiveness," concludes Mack.

The high-power blend of technical and human processes reaffirms BIA's ISO 9001:2008 certification for its Document Review Services' Quality Management System as proof of the excellence of BIA's Document Review Services and its document management process.  Certified by NS
'/>"/>

SOURCE Business Intelligence Associates, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Roche and Catalyst Resources Team to Explore RIA Healthcare Collaboration Solutions for Enhanced Clinical Diagnosis and Education
2. Inventor of Green Catalysts Offers Solutions for Cleaning Toxins and Pollutants in the Environment
3. Catalyst Pharmaceutical Partners To Transfer To NASDAQ Capital Market
4. Catalyst Pharmaceutical Partners Licenses Exclusive Rights to New Class of GABA Aminotransferase Inhibitors From Northwestern University
5. Increasing Regulation and Economic Volatility Key Catalysts for Risk Management in the Food System, Agribusiness and Beverage Industry, Says Report from Aon Analytics
6. Catalyst Biosciences Announces Agreement With MedImmune to Discover and Develop Engineered Protease Therapeutics
7. Wyeth Pharmaceuticals and Catalyst Biosciences Announce Agreement to Develop and Commercialize Factor VIIa Products
8. Cardiva Medical, Inc. Receives FDA Clearance for the Catalyst(TM)III System, First in Class Drug Coated Vessel Closure Device
9. Catalyst Pharmaceutical Partners Reports First Quarter 2009 Financial Results
10. Americas #1 Companion Gets Respect: The CATalyst 2009 Top 10 Cat-Friendly Cities
11. Catalyst to Focus Resources on its Lead Indication for CPP-109; Cocaine Addiction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... Daily Gossip reveals in its review that the Flat Belly ... loss tips. , The author of the new method ... to implement. Users don’t have to worry, as they will ... counting calories. , The Flat Belly Forever program was ... weeks weight loss program to help sufferers model the perfect ...
(Date:7/31/2014)... its latest blog post, Best Drug Rehabilitation , which ... during a stay in rehab can make a big difference ... at 10 tips to help drug or alcohol addicts cope ... process, and one that former addicts and those who support ... Drug Rehabilitation’s CEO Per Wickstrom . , According ...
(Date:7/31/2014)... The study, The Truth Behind ... episode of care payments for four clinical areas—congestive heart ... replacements (hips and knees). Using the definition of ... Care Improvement program, the study examines these clinical areas ... the country. , “Our study reaffirms that, in most ...
(Date:7/30/2014)... 30, 2014 The Mesothelioma ... Penn's Abramson Cancer Center, will host a regional ... experts in the field of mesothelioma. September 26 marks ... is open to the public, and specifically aimed at ... who have been exposed to asbestos. , The conference ...
(Date:7/30/2014)... events experienced during deployment, returning National Guard soldiers ... if faced with civilian life setbacks, including job ... legal problemsall commonplace in military families. Results of ... School of Public Health are published online in ... , Alcohol abuse is a major concern for ...
Breaking Medicine News(10 mins):Health News:New Best Drug Rehabilitation Blog Posts Looks at 10 Tips for Coping After Drug or Alcohol Rehab 2Health News:Recent Research Finds a New Driver of Cost Variation in Episode Payments 2Health News:Recent Research Finds a New Driver of Cost Variation in Episode Payments 3Health News:September Events: Regional Conference on Mesothelioma in Philadelphia 2Health News:September Events: Regional Conference on Mesothelioma in Philadelphia 3Health News:Vets' alcohol problems linked to stress on the home front 2
... Company (NYSE: PG ) announced net sales growth of ... Organic sales were up five,percent, delivering at the mid-point of ... led by strong growth in the Beauty, Fabric,Care & Home ... earnings,per share increased 12 percent to $1.03 for the quarter., ...
... /Xinhua-PRNewswire-FirstCall/ -- China Medical,Technologies, Inc. (the "Company") ... device company that develops, manufactures and markets ... it will be attending the,Credit Suisse Asian ... Location: Beijing, China, China Medical ...
... Melting Pot Restaurants join,St. Jude Children,s Research Hospital in ... - Dec. 31 to "give thanks for the healthy ... not.", "From the beginning, our involvement with St. ... said Kendra Sartor, vice president,of brand development for The ...
... growth, the global fluoroscopy and mobile C-arms market is forecast to ... form a large chunk of total market, particularly in the developed ... Asia-Pacific. , ... San Jose, CA (PRWEB) October 29, ...
... campaign against the threat of Coronary Heart Disease joined by Royle Family ... ... Tomlinson has warned British men against the threat of Coronary Heart Disease ... that he did not take his heart health seriously in the past ...
... 28 Today the ... responded to a request ... to hold an unnecessary,debate., ... letters, please visit:, http://www.noonprop8.com/downloads/FSchubert102808.pdf ...
Cached Medicine News:Health News:P&G Reports First Quarter EPS of $1.03 Up 12% on 9% Sales Growth 2Health News:P&G Reports First Quarter EPS of $1.03 Up 12% on 9% Sales Growth 3Health News:P&G Reports First Quarter EPS of $1.03 Up 12% on 9% Sales Growth 4Health News:P&G Reports First Quarter EPS of $1.03 Up 12% on 9% Sales Growth 5Health News:P&G Reports First Quarter EPS of $1.03 Up 12% on 9% Sales Growth 6Health News:P&G Reports First Quarter EPS of $1.03 Up 12% on 9% Sales Growth 7Health News:P&G Reports First Quarter EPS of $1.03 Up 12% on 9% Sales Growth 8Health News:P&G Reports First Quarter EPS of $1.03 Up 12% on 9% Sales Growth 9Health News:P&G Reports First Quarter EPS of $1.03 Up 12% on 9% Sales Growth 10Health News:P&G Reports First Quarter EPS of $1.03 Up 12% on 9% Sales Growth 11Health News:P&G Reports First Quarter EPS of $1.03 Up 12% on 9% Sales Growth 12Health News:P&G Reports First Quarter EPS of $1.03 Up 12% on 9% Sales Growth 13Health News:P&G Reports First Quarter EPS of $1.03 Up 12% on 9% Sales Growth 14Health News:P&G Reports First Quarter EPS of $1.03 Up 12% on 9% Sales Growth 15Health News:P&G Reports First Quarter EPS of $1.03 Up 12% on 9% Sales Growth 16Health News:P&G Reports First Quarter EPS of $1.03 Up 12% on 9% Sales Growth 17Health News:The Melting Pot Joins St. Jude Children's Research Hospital(R) for the Fifth Annual Thanks and Giving(R) Campaign 2Health News:The Melting Pot Joins St. Jude Children's Research Hospital(R) for the Fifth Annual Thanks and Giving(R) Campaign 3Health News:Fluoroscopy and Mobile C-arms Unit Sales to Reach 9.6 Thousand Units by 2012, According to New Report by Global Industry Analysts 2Health News:Fluoroscopy and Mobile C-arms Unit Sales to Reach 9.6 Thousand Units by 2012, According to New Report by Global Industry Analysts 3Health News:Ricky Tomlinson Joins Lloydspharmacy Against Coronary Heart Disease 2Health News:Ricky Tomlinson Joins Lloydspharmacy Against Coronary Heart Disease 3
(Date:7/30/2014)... SAN DIEGO , July 30, 2014  Eisai Inc. ... today that an article based on post-hoc analyses from the ... Loss While on Lorcaserin, Diet, and Exercise as a Predictor ... online issue of Obesity , the official peer reviewed ... was to identify whether there is an early treatment milestone ...
(Date:7/30/2014)... NEW YORK , July 30, 2014 /PRNewswire/ ... new products for oncology supportive care, announced that its ... been featured in an article on OncLive.com titled, "Study ... and Neck Cancers."  Dr. Steve Sonis , a ... growing demand seen in the oncology community for evidence-based ...
(Date:7/30/2014)... July 30, 2014 /PRNewswire-iReach/ -- This is a ... Chinese Heparin sodium (CAS 9041-08-1) & calcium (CAS ... information of Heparin sodium (CAS 9041-08-1) & calcium ... technology. The report then explores global and China,s ... calcium (CAS 37270-89-6) listing their product specification, capacity, ...
Breaking Medicine Technology:Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 2Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 3Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 4Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 5Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 6Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 7Access Pharmaceuticals Featured On OncLive.com 2Access Pharmaceuticals Featured On OncLive.com 3Heparin Sodium & Calcium Industry for Global and Chinese Markets Forecast to 2019 2Heparin Sodium & Calcium Industry for Global and Chinese Markets Forecast to 2019 3Heparin Sodium & Calcium Industry for Global and Chinese Markets Forecast to 2019 4Heparin Sodium & Calcium Industry for Global and Chinese Markets Forecast to 2019 5
... ASSERT Trial Presented at EULAR, BARCELONA, Spain, ... at the European League Against Rheumatism (EULAR),Annual ... with,ankylosing spondylitis (AS) who received REMICADE(R) (infliximab),over ... In addition, REMICADE-treated patients showed sustained,reductions in ...
... Biotech (OMX Nordic: ACTI) presented,pre-clinical results for ... (The,European League Against Rheumatism, <a target="_blank" href=,"http://www.eular.org/">www.eular.org ... pre-clinical data presented show that I-3D has ... an,experimental model for rheumatoid arthritis (RA)", commented ...
Cached Medicine Technology:Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation 2Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation 3Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation 4Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation 5Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation 6Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation 7Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation 8Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation 9Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation 10Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation 11Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation 12New Positive Pre-clinical Data for Active Biotech's RA Project I-3D 2
... System provides anterior column support for single ... T1 to L5. The system consists of ... cages that are stacked to a desired ... Carbon Fiber Reinforced Polymer material emulates the ...
... provides anterior column support for single or ... to L5. The system consists of one ... that are stacked to a desired height, ... Fiber Reinforced Polymer material emulates the biomechanical ...
... Cage system is a carbon fiber reinforced ... and biologic functions of posterior lumbar interbody ... provides a device designed to meet the ... cancellous bone, the best possible bone for ...
... is highly adaptable and therefore suitable for ... to its extraordinary small outer diameter and ... of a simple but secure and reliable ... steering instruments around the corner. These characteristics ...
Medicine Products: